Assessment of Health-Related Quality of Life (hrqol) in Triple-Class–exposed Patients with Relapsed or Refractory Multiple Myeloma (RRMM) Treated with Linvoseltamab in the LINKER-MM1 Trial.
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined